Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Therefore, before recommending GLP-1 therapy broadly in normal-weight populations, policymakers and clinicians must carefully weigh cost-effectiveness alongside clinical outcomes
10.1002/cbf.2816 Cell Biochem
Author(s): 1Department of Biology, Arsanjan Branch, Islamic Azad University, Arsanjan, Iran 2Department of Physiology, Arak University of Medical Sciences, Arak, Iran 3Department of Biology, Damghan Branch, Islamic Azad University, Damghan, Iran *Corresponding Author: Corresponding author at: Department of Physiology, Arsanjan Branch, Islamic Azad University, Arsanjan, Iran
For practitioners providing care to persons with conditions wherein GLP-1RAs are indicated (e.g., obesity, T2DM) and who are smokers, awareness of the potential salutary effects of GLP-1RAs on smoking should be evaluated
Others with more weekly potential may offer other advantages
